Igor Astsaturov

Fox Chase Cancer Center

NIH Rank #40853
  • Early Career

NIH Funding · FY2024

Total Funding
$302.7K
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#40,853
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $302.7K across 2 grants · National rank #40853.

Top grants by award amount

Igor Astsaturov's NIH grant portfolio, ranked by award amount.

  • 5R21CA277402-02R21
    A Phase I Proof-of-Concept Study of CBL0137 Combined with Ipilimumab and Nivolumab Therapy in Locally Advanced or Metastatic Melanoma
    $208.7K
    award amount
  • 1R03CA286669-01R03
    Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer
    $94K
    award amount

Affiliation

Institutions that have administered grants for Igor Astsaturov.

Affiliated with Fox Chase Cancer Center (PA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Fox Chase Cancer Center